![](/img/cover-not-exists.png)
Loss of PTEN expression in colorectal cancer (CRC) metastases (mets) but not in primary tumors predicts lack of activity of cetuximab plus irinotecan treatment
I. Stasi, F. Loupakis, L. Pollina, G. Masi, N. Funel, M. Scartozzi, I. Petrini, D. Santini, S. Cascinu, A. FalconeVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)71596-9
File:
PDF, 89 KB
english, 2008